ArticleActa diabetologica2026
Exploring the role of resistin as a biomarker of early renal changes in pediatric type 1 diabetes mellitus.
Article in Acta diabetologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
aimsEvidence suggests that resistin, through its pro-inflammatory and pro-oxidative actions, may contribute to the development of cardiovascular and kidney diseases. Although resistin has been investigated in insulin-resistant states, data on this cytokine in pediatric patients with type 1 diabetes mellitus (T1DM) remain scarce. This study aimed to examine the relationship between circulating resistin and oxidative stress biomarkers, as well as with urinary albumin excretion in children and adolescents with T1DM.
methodsSerum resistin levels, metabolic control, lipid and redox biomarkers, including prooxidant-antioxidant balance (PAB), advanced oxidation protein products (AOPP), total sulfhydryl (SH) groups, superoxide dismutase (SOD) activity and total antioxidant status (TAS) were determined in 159 pediatric T1DM patients.
resultsThe highest resistin tertile was characterized by the largest proportion of poorly controlled patients (P < 0.05). These patients also showed significantly elevated AOPP and SH-groups, while the patients in the lowest tertile exhibited significantly higher PAB. Resistin correlated positively with urinary albumin excretion, AOPP and hsCRP, and negatively with PAB (P < 0.05). Patients in the highest resistin tertile had a greater likelihood of early elevation of albumin excretion (OR = 2.27; 97% CI: 1.00-5.15; P = 0.05). This relationship remained significant after adjustment for demographic, lipid and redox parameters, but attenuated after adjustment for diabetes-related parameters.
conclusionsElevated serum resistin concentrations in pediatric patients with T1DM were associated with suboptimal metabolic control, enhanced oxidative stress and an early increase in urinary albumin excretion rate. Further studies are needed to clarify the mechanisms through which resistin contributes to early kidney dysfunction in T1DM.
Indexed as
Identifiers
42189219What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.